RVNC |
Revance Therapeutics, Inc. |
Jun 30, 2024 |
1 |
$2.18 K |
4 |
Jul 2, 2024 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Mar 15, 2024 |
2 |
-$67.5 K |
4 |
Mar 19, 2024 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Feb 29, 2024 |
1 |
$0 |
4 |
Mar 4, 2024 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Jan 31, 2024 |
2 |
$0 |
4 |
Feb 2, 2024 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Dec 31, 2023 |
1 |
$3.24 K |
4 |
Jan 3, 2024 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Aug 11, 2023 |
2 |
-$212 K |
4 |
Aug 15, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Jun 30, 2023 |
2 |
-$30.6 K |
4 |
Jul 5, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Jun 1, 2023 |
2 |
-$98.1 K |
4 |
Jun 5, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
May 1, 2023 |
1 |
-$101 K |
4 |
May 2, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Apr 3, 2023 |
1 |
-$103 K |
4 |
Apr 4, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Mar 15, 2023 |
1 |
-$115 K |
4 |
Mar 17, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Mar 1, 2023 |
1 |
-$107 K |
4 |
Mar 2, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Feb 15, 2023 |
1 |
-$69.2 K |
4 |
Feb 16, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Jan 31, 2023 |
2 |
-$111 K |
4 |
Feb 2, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Jan 20, 2023 |
1 |
-$31 K |
4 |
Jan 23, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Jan 9, 2023 |
3 |
-$101 K |
4 |
Jan 10, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Dec 31, 2022 |
1 |
$7.86 K |
4 |
Jan 3, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Dec 15, 2022 |
1 |
-$33.5 K |
4 |
Dec 16, 2022 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Sep 22, 2022 |
2 |
-$585 K |
4 |
Mar 9, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Jun 30, 2022 |
1 |
$11.3 K |
4 |
Jul 5, 2022 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Mar 15, 2022 |
1 |
-$41.2 K |
4 |
Mar 17, 2022 |
Chief Financial Officer |
RVNC |
Revance Therapeutics, Inc. |
Feb 15, 2022 |
2 |
-$39 K |
4 |
Feb 17, 2022 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Feb 2, 2022 |
2 |
-$739 K |
4 |
May 16, 2023 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Feb 2, 2022 |
1 |
$0 |
4 |
Feb 4, 2022 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Dec 31, 2021 |
1 |
$5.6 K |
4 |
Jan 4, 2022 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Dec 15, 2021 |
1 |
-$24.8 K |
4 |
Dec 17, 2021 |
CFO |
RVNC |
Revance Therapeutics, Inc. |
Jun 30, 2021 |
1 |
$10.7 K |
4 |
Jul 2, 2021 |
CFO |